| 摘要 |
<p>The concentration of glycated hemoglobin, HbA1c, in hemoglobin from diabetic patients is regarded as a useful means of assessing the adequacy of diabetes control. This invention provides a monoclonal antibody which, due to its specific binding of HbA1c, can be used for the determination of HbA1c in blood samples by such analytical methods as radioimmuno assay or enzyme-linked immunosorbent assay.</p> |
